Migræne kliniske forsøg i Tennessee
8 studier for Migræne søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
Study of EVO756 in Adults With Migraine
- Campbell Clinical Research, Franklin
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 2. okt. 2026 · NCT07616128MMA Embolization for Refractory Chronic Migraine
- Semmes Murphey Foundation, Memphis
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT06735833A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Access Clinical Trials Inc /ID# 270280, Nashville
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 22. sep. 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
Rekrutterer
Alder 10 til 17 · Alle køn · Opdateret 21. sep. 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Vanderbilt Medical Center, Nashville
RekruttererFase 4
Alder 18 til 70 · Alle køn · Opdateret 16. sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Access Clinical Trials, Inc. /ID# 228002, Nashville
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Research Associates, Inc., Nashville
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 2. sep. 2026 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- WR-ClinSearch, LLC, Chattanooga
- Access Clinical Trials, Inc, Nashville
- Clinical Research Associates, Inc., Nashville
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.